Journal of Vascular Surgery
Volume 50, Issue 3 , Pages 581-589.e1 , September 2009

Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: Analysis of patient self-assessment and imaging

Presented at the Twenty-first annual meeting of American Venous Forum in Phoenix, Arizona on February 14, 2009.

  • Woo-Sung Yun, MD

      Affiliations

    • Congenital Vascular Malformation Clinic, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Young-Wook Kim, MD

      Affiliations

    • Congenital Vascular Malformation Clinic, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • Corresponding Author InformationReprint requests: Young-Wook Kim, MD, Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul, Korea, 135-710
    • ,
  • Kyung-Bok Lee, MD

      Affiliations

    • Congenital Vascular Malformation Clinic, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Dong-Ik Kim, MD

      Affiliations

    • Congenital Vascular Malformation Clinic, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Kwang-Bo Park, MD

      Affiliations

    • Congenital Vascular Malformation Clinic, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Keon-Ha Kim, MD

      Affiliations

    • Congenital Vascular Malformation Clinic, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Young-Soo Do, MD

      Affiliations

    • Congenital Vascular Malformation Clinic, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Byung-Boong Lee, MD

      Affiliations

    • Center for Vein, Lymphatics and Vascular Malformation, Georgetown University School of Medicine, Washington, D.C.

Received 5 February 2009 ,Accepted 26 March 2009.

References 

  1. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003;37:533–538
  2. Loose DA. Surgical management of venous malformations. Phlebology. 2007;22:276–282
  3. Lee BB, Laredo J, Kim YW, Neville R. Congenital vascular malformations: general treatment principles. Phlebology. 2007;22:258–263
  4. Lee BB, Kim DI, Huh S, Kim HH, Choo IW, Byun HS, et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg. 2001;33:764–772
  5. Szilagyi DE, Smith RF, Elliott JP, Hageman JH. Congenital arteriovenous anomalies of the limbs. Arch Surg. 1976;111:423–429
  6. Trout HH, McAllister HA, Giordano JM, Rich NM. Vascular malformations. Surgery. 1985;97:36–41
  7. Yakes WF, Haas DK, Parker SH, Gibson MD, Hopper KD, Mulligan JS, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989;170:1059–1066
  8. Yakes WF, Luethke JM, Parker SH, Stavros AT, Rak KM, Hopper KD, et al. Ethanol embolization of vascular malformations. Radiographics. 1990;10:787–796
  9. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Intervent Radiol. 2004;15:431–445
  10. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104:1–11discussion 12-5
  11. Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223:639–644
  12. Rautio R, Laranne J, Kahara V, Saarinen J, Keski-Nisula L. Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck. Acta Radiol. 2004;45:738–745
  13. Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol. 2003;33:99–103
  14. Rosenblatt M. Endovascular management of venous malformations. Phlebology. 2007;22:264–275
  15. Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg. 2008;47:1292–1299
  16. Choi YH, Han MH KOK, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol. 2002;13:475–482
  17. Dubois JM, Sebag GH, De Prost Y, Teillac D, Chretien B, Brunelle FO. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology. 1991;180:195–198
  18. Pascarella L, Bergan JJ, Yamada C, Mekenas L. Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg. 2005;19:457–464
  19. Tan KT, Kirby J, Rajan DK, Hayeems E, Beecroft JR, Simons ME. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol. 2007;18:343–351
  20. Lee KB, Kim DI, Oh SK, Do YS, Kim KH, Kim YW. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation. J Vasc Surg. 2008;48:1286–1291
  21. Rimon U, Garniek A, Galili Y, Golan G, Bensaid P, Morag B. Ethanol sclerotherapy of peripheral venous malformations. Eur J Radiol. 2004;52:283–287

 Competition of interest: none.

 Additional material for this article may be found online at www.jvascsurg.org.

PII: S0741-5214(09)00801-5

doi: 10.1016/j.jvs.2009.03.058

Journal of Vascular Surgery
Volume 50, Issue 3 , Pages 581-589.e1 , September 2009

Article Tools

* Image Usage & Resolution